Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients
- 7 February 2012
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 11 (2) , 307-311
Abstract
Women from Pakistan and India are more often diagnosed with early-onset breast cancer than Caucasian women. Given that only 12% of Pakistani women diagnosed with breast cancer at or before 30 years of age have previously been shown to harbor germ line mutations in the breast cancer susceptibility genes BRCA1 and BRCA2, the genetic causes of the majority of early-onset cases are unexplained. Since germ line mutations in the tumor suppressor gene TP53 predispose women to early-onset breast cancer, we assessed the prevalence of TP53 mutations in 105 early-onset breast cancer patients from Pakistan, who had previously been found to be negative for BRCA1 and BRCA2 germ line mutations. The patient group included 67 women diagnosed with early-onset breast cancer at or before age 30 with no family history of breast or ovarian cancer (EO30NFH group) and 38 women diagnosed with breast cancer at or before age 40 with one or more first- or second-degree relatives with breast or ovarian cancer (EO40FH group). Mutation analysis of the complete TP53 coding region was performed using denaturing high-performance liquid chromatography analysis, followed by DNA sequencing of variant fragments. One deleterious mutation, c.499-500delCA in exon 5, was identified in the 105 breast cancer patients (1%). This mutation is novel in the germ line and has not been described in other populations. It was detected in a 28-year-old patient with no family history of breast or ovarian cancer. This mutation is rare as it was not detected in additional 157 recently recruited non-BRCA1 and non-BRCA2-associated early-onset breast cancer patients. Our findings show that TP53 mutations may account for a minimal portion of early-onset breast cancer in Pakistan.Keywords
This publication has 38 references indexed in Scilit:
- Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survivalBreast Cancer Research and Treatment, 2011
- Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family StudyCancer Research, 2010
- Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysisBMC Cancer, 2010
- The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30Familial Cancer, 2009
- Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer familiesBreast Cancer Research and Treatment, 2007
- TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancerBreast Cancer Research, 2007
- Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patientsInternational Journal of Cancer, 2006
- BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesEuropean Journal of Cancer, 2006
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.Clinical Cancer Research, 2006